Skip to content

Effects of dexmedetomidine on intravenous controlled analgesia sufentanil ED50 in patients after cesarean section

Effects of dexmedetomidine on intravenous controlled analgesia sufentanil ED50 in patients after cesarean section

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000041302
Enrollment
Unknown
Registered
2020-12-23
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iv controlled analgesia after cesarean section

Interventions

Experimental group:Dexmedetomidine + sufentanil

Sponsors

Nanchong Central Hospital of Sichuan Province
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 42 Years

Inclusion criteria

Inclusion criteria: 1. Subjects aged 20-42 years; 2. ASA grade: I-II; 3. Primipara with single birth at 37-40 weeks of gestation; 4. The first set of doctors in the same group underwent elective cesarean section on the same day; 5. Subjects willing to breastfeed.

Exclusion criteria

Exclusion criteria: 1. Subjects allergic to adrenergic agonists and opioids; 2. There were subjects who often used analgesics and sedatives before operation; 3. Subjects with previous psychiatric history, spinal and lower abdominal surgery history; 4. Subjects sensitive to pain; 5. Subjects with conduction block and sinus bradycardia on ECG before operation; 6. Those who can't understand pain score and those who don't know how to use PCIA; 7. Subjects who have participated in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Pain score;Sufentanil dosage;

Countries

China

Contacts

Public ContactWuchang Fu

Nanchong Central Hospital of Sichuan Province

14834043@qq.com+86 13990820494

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026